Put companies on watchlist
Nutex Health
ISIN: US67079U1088
WKN: A3DG4J
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Nutex Health · ISIN: US67079U1088 · PR Newswire (ID: 20240826LA90736)
26 August 2024 11:30AM

NUTEX HEALTH OPENS POST FALLS ER & HOSPITAL, ITS FIRST HOSPITAL IN IDAHO


Nutex Health expands its footprint with Post Falls ER & Hospital on the border of Idaho and Washington, serving patients from both states.

POST FALLS, Idaho, Aug. 26, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced the opening of Post Falls ER & Hospital, located at 497 S Beck Road in Post Falls, Idaho.

The staff of medical experts at Post Falls ER & Hospital are bringing the communities in Post Falls and Coeur d'Alene, Idaho and Spokane, Washington 24/7/365 days of concierge-level care. The roughly 25,000 square foot state-of-the-art facility houses 12 ER beds, 5 inpatient beds, 1 procedure room, in-house laboratory services, an in-house pharmacy, and an imaging suite, including MRI, CT scan, X-ray, and Ultrasound.   

"We are excited to bring this innovative Hospital and Emergency care model to our community. We believe the concierge model with minimal wait times will resonate well with our future patients and families," said Robert Seeley, M.D., Co-Chief Medical Officer at Post Falls ER & Hospital.

"We have assembled an amazing team of caregivers who are thrilled about our new hospital and eager to provide the highest quality of care possible," said McLane Simpson, M.D., Co-Chief Medical Officer at Post Falls ER & Hospital.

In comparison to the traditional hospital systems, patients will be met with the convenience of emergency care in the comfort of a relaxing environment, a short wait time, and ample one-on-one time with a board-certified physician and emergency trained staff. If indications are needed for additional treatments beyond the ER, Post Falls ER & Hospital is equipped with comfortable and state-of-the-art medical beds for longer inpatient stays.

Following the opening of Green Bay ER & Hospital, this is the Company's second new hospital opening of 2024.

"We are honored to have the opportunity to bring our brand of medicine to serve the great citizens of Post Falls, Coeur d'Alene, Spokane and beyond," said Tom Vo, M.D., MBA, Chairman and Chief Executive Officer of Nutex Health.

About Nutex Health Inc.

Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division.

The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 22 facilities in 10 states.

The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups. Our cloud-based proprietary technology platform aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers, allowing us to deliver greater quality care more efficiently.

Forward-Looking Statements

Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act , economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2023 and in the Quarterly Report on Form 10-Q for the period ended March 31, 2024 under the heading "Risk Factors" in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.

 

Cision View original content:https://www.prnewswire.com/news-releases/nutex-health-opens-post-falls-er--hospital-its-first-hospital-in-idaho-302229930.html

SOURCE Nutex Health, Inc.

Visual performance / price development - Nutex Health
Smart analysis and research tools can be found here.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2024
PR Newswire
Contact:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942